SBIR-STTR Award

Markerless Motion Capture for the Clinical Assessment of Human Movement
Award last edited on: 9/20/13

Sponsored Program
SBIR
Awarding Agency
NIH : NCATS
Total Award Amount
$1,072,342
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Stefano Corazza

Company Information

Animotion Inc (AKA: Mixamo)

2415 3rd Street Suite 239
San Francisco, CA 94107
   (415) 255-7455
   stefano@animotion-inc.com
   www.animotion-inc.com
Location: Single
Congr. District: 12
County: San Francisco

Phase I

Contract Number: 1R43AR058023-01A1
Start Date: 8/15/10    Completed: 7/31/11
Phase I year
2010
Phase I Amount
$124,139
Loss of ambulatory function due to disease and injury has an increasing societal impact as the US population ages and has an even greater impact on veterans. The development of methods for effective assessment and rehabilitation of impairments of the ambulatory function would have a great positive impact on the active life span of the US population. The overall objective of this project is to adapt a previously developed markerless motion capture system prototype to simply, efficiently and accurately provide 3D measurements of human movement for applications in biomechanical and clinical practice. The specific focus of this study is the implementation of additional development on the new markerless system that will permit the system to be operated by a non-technical user in a clinical environment by developing and testing a new user interface and automatically generating subject-specific anatomical models of the subjects to support clinicians in their diagnostic/rehabilitative work. ,

Public Health Relevance:
The overall objective of this project is to further develop and productize a markerless motion capture system for applications in biomechanical and clinical practice. The markerless system, as opposed to traditionally used marker based systems, would provide simple, cost effective, efficient and accurate 3D measurements of human movement for applications in biomechanical and clinical practice. The specific focus of this study is additional development on the new markerless system that will permit the system to be operated by a non- technical user in a clinical environment by developing and testing a new user interface and automatically generating subject-specific anatomical models of the subjects

Thesaurus Terms:
Achievement;Achievement Attainment;Age;Algorithms;Anatomic;Anatomic Models;Anatomical Sciences;Anatomy;Anterior Cruciate Ligament;Arthritis, Degenerative;Articulation;Arts;Au Element;Beds;Benchmarking;Best Practice Analysis;Biomechanics;Clinical;Clinical Data;Clinical Assessments;Collection;Data;Data Banks;Data Bases;Data Security;Data Set;Data Awareness;Databank, Electronic;Databanks;Database, Electronic;Databases;Dataset;Degenerative Polyarthritis;Development;Development And Research;Diagnostic;Disease;Disorder;Effectiveness;Electromagnetic, Laser;Environment;Equipment;Evaluation;Gait;Generations;Goals;Gold;Graph;Height;Human;Human Figure;Human Body;Human, General;Impairment;Injury;Joints;Kinetic;Kinetics;Lasers;Length Of Life;Location;Locomotion;Longevity;Man (Taxonomy);Man, Modern;Manuals;Measurement;Methods;Modeling;Models, Anatomic;Models, Anatomical;Motion;Movement;Musculoskeletal;Orthopedic;Orthopedic Surgical Profession;Orthopedics;Osteoarthritis;Osteoarthrosis;Outcome;Output;Patient Data Confidentiality;Patient Data Privacy;Patients;Pattern;Physical Health Services / Rehabilitation;Population;Process;Quantitative Evaluations;R & D;R&D;Radiation, Laser;Radiation, X-Rays;Radiation, X-Rays, Gamma-Rays;Rehabilitation;Rehabilitation Therapy;Rehabilitation, Medical;Reporting;Roentgen Rays;Scanning;Science Of Anatomy;Security, Data;Shapes;Surface;Surgeon;System;System, Loinc Axis 4;Technology;Testing;Time;Validation;Veterans;Work;X-Radiation;X-Rays;Xrays;Anatomy;Base;Body Movement;Bone Visualization;Clinical Data Repository;Clinical Data Warehouse;Clinical Practice;Commercialization;Computerized Data Processing;Cost Effective;Data Acquisition;Data Management;Data Processing;Data Repository;Degenerative Joint Disease;Disease/Disorder;Experiment;Experimental Research;Experimental Study;Hypertrophic Arthritis;Improved;Information Security;Kinematics;Life Span;Lifespan;Ligament Injury;Meetings;Method Development;Prototype;Public Health Relevance;Rehabilitative;Relational Database;Research And Development;Research Study;Sharing Data;Signal Processing;Skeletal Visualization;Tool;Usability

Phase II

Contract Number: 9R44TR000575-02
Start Date: 9/10/12    Completed: 2/28/14
Phase II year
2012
(last award dollars: 2013)
Phase II Amount
$948,203

The overall objective of this project is to productize and commercialize a markerless motion capture system for applications in biomechanical and clinical practice. The markerless system, as opposed to traditionally used marker based systems, would provide simple, cost effective, efficient and accurate 3D measurements of human movement for applications in biomechanical and clinical practice. The specific focus of this Phase II project is to make the prototype validated in Phase II a robust product and to commercialize it for gait analysis and sport medicine applications.

Public Health Relevance:
This application proposes the development of a commercial product consisting of a markerless motion capture system that will change the way clinical assessment of human motion is achieved. The grant will enable the completion of the developments and the commercialization of this technology in research and in clinical practices. In Phase I Mixamo and Stanford University have collaborated successfully in the realization of a prototype and its validation in a clinical setup. The two institutions have the most cutting edge researchers in the human motion analysis field as members of their teams. Motion capture is one of Mixamo, Inc's. core businesses and the Stanford Biomotion Lab is where the markerless technology was born. The founding CEO of Mixamo, Stefano Corazza, has been working on the early stagees of the technology at the Stanford Biomotion Lab and he is P.I. of the present grant. In this Phase II application Mixamo is taking the lead in making a product ready for the market and commercializing it. The technology has come a long way and is ready for a revolutionary impact in the market of clinical gait analysis and biomechanics.